The Health Science Center is the first study site in the United States to offer a clinical trial evaluating a promising new immunotherapy agent in children and young adults who do not respond well to traditional therapy or whose cancer comes back.
Research studies conducted by the CTRC and School of Medicine of the Health Science Center were presented during the 38th annual AACR-CTRC San Antonio Breast Cancer Symposium held Dec. 8-12 at the Henry B. Gonzalez Convention Center.
William L. Henrich, M.D., MACP, president of the Health Science Center, personally thanked Baptist Health Foundation of San Antonio trustees Dec. 3 for their unprecedented grant of $1,050,000 toward South Texas’ first Institute for Alzheimer and Neurodegenerative Disease. The grant is the largest in the foundation’s history.
A new research study in Bexar and surrounding counties will examine whether a drug already approved for slowing blood loss in other conditions will reduce the risk of death in adult trauma patients in shock from severe bleeding.